Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Google Scholar citation report
Citations : 1437
Journal of Clinical & Experimental Pathology received 1437 citations as per Google Scholar report
Journal of Clinical & Experimental Pathology peer review process verified at publons
Indexed In
- Index Copernicus
- Google Scholar
- Sherpa Romeo
- Open J Gate
- Genamics JournalSeek
- JournalTOCs
- Cosmos IF
- Ulrich's Periodicals Directory
- RefSeek
- Directory of Research Journal Indexing (DRJI)
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- ICMJE
- world cat
- journal seek genamics
- j-gate
- esji (eurasian scientific journal index)
Useful Links
Recommended Journals
Related Subjects
Share This Page
Cluster of differentiations as biomarker in differentiation between ALL and AML
2nd International Conference on Digital Pathology & Image Analysis
Walaa Fikry Elbossaty
Damietta University, Egypt
ScientificTracks Abstracts: J Clin Exp Pathol
Abstract
Introduction & Aim: Antigen surface markers represent as the new prognostic tool for detection of acute leukemia. To aim of this study is to investigate the prevalence expression of lymphoid and myeloid antigen lineage in acute leukemias. Material & Methods: This study included 100 acute leukemias patients. Specimens were selected from consecutive patients who had sufficient material available. Among the 100 patients in which a detailed history, hematological, clinical and immunophenotyping analysis were performed. This study showed distribution of immunophenotyping characters between studied AML and ALL cases. Results: The most abundant immunophenotyping features in acute myeloid leukemia were cMPO, CD33, CD117, CD13, CD14 and CD64, while the most abundant immunophenotyping features in acute lymphoblastic leukemia were CD19, CD79a, TdT, CD20, CD10 and CD34. Conclusion: cMPO which act as independent prognostic factor for AML, CD10 and TdT can be used as independent prognostic factor to differentiate between ALL and AML.Biography
Walaa Fikry Elbossaty is a PhD Post Research Fellow, Department of Chemistry, Faculty of Science-Damietta, Egypt. She received BSc (Chemistry/Biochemistry), MSc in Biochemistry from Mansoura University and PhD in Biochemistry/Molecular Biology from Damietta University.
